Literature DB >> 30363461

Posterior Reversible Encephalopathy Syndrome in a Patient With Multiple System Atrophy.

Sarah Debray1, Saartje Van de Vondel2, Thomas Tousseyn3, Dietmar Rudolf Thal3,4, Maarten Dewil5.   

Abstract

Entities:  

Keywords:  fludrocortisone; midodrine; multiple system atrophy (MSA); orthostatic hypotension; posterior reversible encephalopathy syndrome (PRES)

Year:  2017        PMID： 30363461      PMCID： PMC6174484          DOI： 10.1002/mdc3.12495

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  5 in total

1.  Posterior reversible encephalopathy syndrome in multiple system atrophy.

Authors:  Tom P Franken; Philippe Demaerel; Wim Vandenberghe
Journal:  Parkinsonism Relat Disord       Date:  2016-03-21       Impact factor: 4.891

2.  Reversible posterior leukoencephalopathy syndrome in a patient with multiple system atrophy: a possible association with oral midodrine treatment.

Authors:  Joong-Seok Kim; Kwang-Soo Lee; Sung-Chul Lim; Jae-Young Ahn; In-Uk Song; Yeong-In Kim; Bum-Soo Kim; Hee-Tae Kim
Journal:  Mov Disord       Date:  2007-05-15       Impact factor: 10.338

Review 3.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

4.  Frequency of nocturnal sudden death in patients with multiple system atrophy.

Authors:  T Shimohata; T Ozawa; H Nakayama; M Tomita; H Shinoda; M Nishizawa
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

Review 5.  Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.

Authors:  Kristina H Haugaa; Trine F Haland; Ida S Leren; Jørg Saberniak; Thor Edvardsen
Journal:  Europace       Date:  2015-10-25       Impact factor: 5.214
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.